Reproducibility in PD-L1 Immunohistochemistry Quantification through the Tumor Proportion Score and the Combined Positive Score: Could Dual Immunostaining Help Pathologists?
Cancers · 16.05.2023 · 15 (10) · 2768
DOI: 10.3390/cancers15102768 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 16.05.2023. Verfasst von Anaïs Mercier und 5 weiteren Autor:innen. Beteiligte Einrichtung: CHU de Brest, Service D'anatomie et Cytologie Pathologiques, F-29200 Brest, France. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
We studied the pathologists’ agreements in quantifying PD-L1 expression through the tumor proportion score (TPS) and the combined positive score (CPS) using single PD-L1 immunohistochemistry (S-IHC) and double immunohistochemistry (D-IHC) combining PD-L1 staining and tumor cell markers. S-IHC and D-IHC were applied to 15 cancer samples to generate 60 digital IHC slides (30 whole slides images and 30 regions of interest of 1 mm2) for PD-L1 expression quantification using both TPS and CPS, twice by four pathologists. Agreements were estimated calculating intraclass correlation coefficients (ICC). Both S-IHC and D-IHC slides analyses resulted in excellent (for TPS, ICC > 0.9) to good (for CPS, ICC > 0.75) inter- and intra-pathologist agreements with slightly higher ICC with D-IHC than with S-IHC. S-IHC resulted in higher TPS and CPS than D-IHC (+5.6 and +6.1 mean differences, respectively). High reproducibility in the quantification of PD-L1 expression is attainable using S-IHC and D-IHC.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- CHU de Brest, Service D'anatomie et Cytologie Pathologiques, F-29200 Brest, France.
- LBAI, UMR1227, Inserm, CHU de Brest, Univ Brest, F-29200 Brest, France.
ORCID-Profile: Arnaud Uguen
Zitieren
APA
Mercier, A., Conan-Charlet, V., Quintin-Roué, I., Doucet, L., Marcorelles, P., & Uguen, A. (2023). Reproducibility in PD-L1 Immunohistochemistry Quantification through the Tumor Proportion Score and the Combined Positive Score: Could Dual Immunostaining Help Pathologists?. Cancers, 15(10), 2768. https://doi.org/10.3390/cancers15102768
Vancouver
Mercier A, Conan-Charlet V, Quintin-Roué I, Doucet L, Marcorelles P, Uguen A. Reproducibility in PD-L1 Immunohistochemistry Quantification through the Tumor Proportion Score and the Combined Positive Score: Could Dual Immunostaining Help Pathologists?. Cancers. 2023;15(10):2768. doi:10.3390/cancers15102768
BibTeX
@article{Mercier2023,
author = {Mercier, Anaïs and Conan-Charlet, Virginie and Quintin-Roué, Isabelle and Doucet, Laurent and Marcorelles, Pascale and Uguen, Arnaud},
title = {Reproducibility in PD-L1 Immunohistochemistry Quantification through the Tumor Proportion Score and the Combined Positive Score: Could Dual Immunostaining Help Pathologists?},
journal = {Cancers},
year = {2023},
volume = {15},
number = {10},
pages = {2768},
doi = {10.3390/cancers15102768}
}
EUVIMED